Loading...
Isoray, Inc.
ISR•AMEX
HealthcareMedical - Devices
$0.38
$0.00(0.00%)
Isoray, Inc. (ISR) Stock Overview
Explore Isoray, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for ISRStats details for ISR are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for ISRAnalyst Recommendations details for ISR are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
CEO
Ms. Lori A. Holmes-Woods
Employees
66
Headquarters
350 Hills Street, Richland, WA
Founded
2002